Aspects of 6-[18F]fluoro-L-DOPA preparation: Deuterochloroform as a substitute solvent for Freon 11

NuklearMedizin

Volumn 47, Issue 1, 2008, Pages 62-64

  Fuchtner F ^a   Zessin, J ^a   Mading P ^a   Wust F ^a  

^a INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

Author keywords

6 18F fluoro L DOPA; Deuterochloroform; Electrophilic radiofluorodestannylation; Freon 11 substitution

Indexed keywords

6 FLUORO LEVODOPA F 18; TRACER; UNCLASSIFIED DRUG; 2,6 DIFLUORO 3,4 DIHYDROXYPHENYLALANINE; 2,6-DIFLUORO-3,4-DIHYDROXYPHENYLALANINE; CHLOROFLUOROCARBON; CHLOROFORM; DEUTERIUM; DOPA; DRUG DERIVATIVE; FLUORINE; SOLVENT;

ARTICLE; FLUORINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROLYSIS; PURIFICATION; SYNTHESIS;

CHLOROFLUOROCARBONS, METHANE; CHLOROFORM; DEUTERIUM; DIHYDROXYPHENYLALANINE; FLUORINE RADIOISOTOPES; SOLVENTS;

EID: 39449115631     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0112     Document Type: Article

References (12)

1. Brink I, Hentschel M, Neumann HPH et al. FDOPA PET als Paradigma molekularer Bildgebung in der Onkologie. Der Nuklearmediziner 2007; 30: 70-82.
2. 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med 2006; 47: 904-911.
3. 18F]fluoro-L-DOPA. Appl Radiat Isot 1999; 51: 389-394.
4. 18F]Fluoro-L-DOPA by radiofluorodestannylation: a short and simple synthesis of a new labeling precursor. J Label Compd Radiopharm 1998; 41: 105-114.
5. 18F]fluoro-L-DOPA preparation: Precursor synthesis, preparative HPLC purification and determination of radiochemical purity. Nucl Med Biol 2002; 29: 477-481.
6. 18F]fluoro-DOPA. Annual Report, Institute of Bioinorganic and Radiopharmaceutical Chemistry 1996; FZR-165: 153-156.
7. 18F]fluoro-L-DOPA. Appl Radiat Isot 2003; 58: 575-578.
8. 18F]fluoro-L-DOPA. University Medical Center Groningen, Annual Report, PET Center 2004; 43-45.
9. Lösungsmittel-Rückstände. Europäisches Arzneibuch. 5. Ausgabe, Grundwerk 2005; 733.
10. Meyer GJ, Waters SL, Coenen HH et al. PET radiopharmaceuticals in Europe: current use and data relevant for the formulation of summaries of product characteristics (SPCs). Eur J Nucl Med 1995; 22: 1420-1432.
11. 18F]fluoro-L-dopa. Appl Radiat Isot 1992; 43: 989-996.
12. 18F]FMT): efficient synthesis and comparison of radiolabeling. Appl Radiat Isot 2004; 61: 1289-1294.